AJA FREEMAN: Open Payments
NPI 1689338931 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 47 payments from 15 companies in 2025. Trend: 2023 $698 · 2024 $1,019 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $220 |
| Sage Therapeutics, LLC | 9 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Ethicon US, LLC | 2 | $81 |
| PFIZER INC. | 3 | $69 |
| Hologic Sales and Service, LLC | 3 | $69 |
| Exeltis, USA Inc. | 4 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $35 |
Products named: Veozah, ZURZUVAE, APTIMA, SLYND, Qelbree, ABRYSVO, Mirena, Lynkuet.
Industry payments across MD — which companies pay providers there.
